{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T10:08:28Z","timestamp":1764238108216,"version":"3.40.5"},"reference-count":48,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2015,5,1]],"date-time":"2015-05-01T00:00:00Z","timestamp":1430438400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","gynecologiconcology-online.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2015,5]]},"DOI":"10.1016\/j.ygyno.2015.02.021","type":"journal-article","created":{"date-parts":[[2015,2,28]],"date-time":"2015-02-28T03:08:53Z","timestamp":1425092933000},"page":"280-284","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"title":["Improving quality and decreasing cost in gynecologic oncology care. Society of gynecologic oncology recommendations for clinical practice"],"prefix":"10.1016","volume":"137","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4808-3805","authenticated-orcid":false,"given":"B.J.","family":"Rimel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William M.","family":"Burke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert V.","family":"Higgins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paula S.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher V.","family":"Lutman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lynn","family":"Parker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ygyno.2015.02.021_bb0005","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.ygyno.2011.07.014","article-title":"Recurrence patterns and surveillance for patients with early stage endometrial cancer","volume":"123","author":"Salani","year":"2011","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2015.02.021_bb0010","first-page":"6","article-title":"Diagnosis of recurrent cervical carcinoma after radical hysterectomy","volume":"71","author":"Larson","year":"1988","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.ygyno.2015.02.021_bb0015","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.ajog.2011.03.008","article-title":"Posttreatment surveillance and diagnosis of recurrence in women with gynecologic malignancies: Society of Gynecologic Oncologists recommendations","volume":"204","author":"Salani","year":"2011","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.ygyno.2015.02.021_bb0020","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.ygyno.2006.05.013","article-title":"Cost-effectiveness of routine vaginal cytology for endometrial cancer surveillance","volume":"103","author":"Bristow","year":"2006","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2015.02.021_bb0025","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1097\/AOG.0b013e31827499a9","article-title":"The utility and management of vaginal cytology after treatment for endometrial cancer","volume":"121","author":"Novetsky","year":"2013","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.ygyno.2015.02.021_bb0030","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.ygyno.2013.09.008","article-title":"Post treatment surveillance of type II endometrial cancer patients","volume":"131","author":"Zakhour","year":"2013","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2015.02.021_bb0035","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1006\/gyno.2000.5860","article-title":"Posttherapy surveillance of women with cervical cancer: an outcomes analysis","volume":"78","author":"Bodurka-Bevers","year":"2000","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2015.02.021_bb0040","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1097\/AOG.0b013e3182271fdd","article-title":"Cervicovaginal cytology in the detection of recurrence after cervical cancer treatment","volume":"118","author":"Rimel","year":"2011","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.ygyno.2015.02.021_bb0045","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.ygyno.2013.05.037","article-title":"A cost analysis of colposcopy following abnormal cytology in posttreatment surveillance for cervical cancer","volume":"130","author":"Tergas","year":"2013","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2015.02.021_bb0050","doi-asserted-by":"crossref","first-page":"S241","DOI":"10.1016\/j.ygyno.2007.07.025","article-title":"Pattern of failure and value of follow-up procedures in endometrial and cervical cancer patients","volume":"107","author":"Sartori","year":"2007","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2015.02.021_bb0055","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1006\/gyno.1995.1262","article-title":"Postsurgical surveillance of patients with FIGO stage I\/II endometrial adenocarcinoma","volume":"59","author":"Berchuck","year":"1995","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2015.02.021_bb0250","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.ygyno.2006.02.011","article-title":"Cancer Care Ontario program in evidence-based care gynecology cancer disease site G","volume":"101","author":"Fung-Kee-Fung","year":"2006","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2015.02.021_bb0070","first-page":"1977","article-title":"An intensive follow-up does not change survival of patients with clinical stage 1 endometrial cancer","volume":"20","author":"Gadducci","year":"2000","journal-title":"Anticancer Res."},{"issue":"Suppl. 1","key":"10.1016\/j.ygyno.2015.02.021_bb0075","doi-asserted-by":"crossref","first-page":"64S","DOI":"10.2967\/jnumed.108.057257","article-title":"The role of 18F-FDG PET in assessing therapy response in cancer of the cervix and ovaries","volume":"50","author":"Schwarz","year":"2009","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.ygyno.2015.02.021_bb0080","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1148\/radiol.2332031800","article-title":"PET\/CT in patients with persistent ovarian cancer: correlation with histologic findings","volume":"233","author":"Sironi","year":"2004","journal-title":"Radiology"},{"key":"10.1016\/j.ygyno.2015.02.021_bb0085","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.ejrad.2008.02.019","article-title":"CA 125, PET alone, PET-CT, CT and MRI in diagnosing recurrent ovarian carcinoma: a systematic review and meta-analysis","volume":"71","author":"Gu","year":"2009","journal-title":"Eur. J. Radiol."},{"key":"10.1016\/j.ygyno.2015.02.021_bb0090","doi-asserted-by":"crossref","first-page":"e184","DOI":"10.1097\/RLU.0b013e31825b2583","article-title":"Revisiting the clinical value of 18F-FDG PET\/CT in detection of recurrent epithelial ovarian carcinomas: correlation with histology, serum CA-125 assay, and conventional radiological modalities","volume":"37","author":"Antunovic","year":"2012","journal-title":"Clin. Nucl. Med."},{"key":"10.1016\/j.ygyno.2015.02.021_bb0095","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1016\/S0140-6736(10)61268-8","article-title":"Early versus delayed treatment of relapsed ovarian cancer (MRC OV05\/EORTC 55955): a randomised trial","volume":"376","author":"Rustin","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.ygyno.2015.02.021_bb0100","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1111\/IGC.0b013e3181e82a7f","article-title":"Clinical utility of positron emission tomography\/computed tomography in the evaluation of suspected recurrent ovarian cancer in the setting of normal CA-125 levels","volume":"20","author":"Bhosale","year":"2010","journal-title":"Int. J. Gynecol. Cancer"},{"key":"10.1016\/j.ygyno.2015.02.021_bb0105","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.1001\/jama.298.19.2289","article-title":"Association of posttherapy positron emission tomography with tumor response and survival in cervical carcinoma","volume":"298","author":"Schwarz","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.ygyno.2015.02.021_bb0110","doi-asserted-by":"crossref","first-page":"3981","DOI":"10.1002\/cncr.25991","article-title":"Impact of post-therapy positron emission tomography on prognostic stratification and surveillance after chemoradiotherapy for cervical cancer","volume":"117","author":"Siva","year":"2011","journal-title":"Cancer"},{"key":"10.1016\/j.ygyno.2015.02.021_bb0115","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.ygyno.2008.08.028","article-title":"Surveillance FDG-PET detection of asymptomatic recurrences in patients with cervical cancer","volume":"112","author":"Brooks","year":"2009","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2015.02.021_bb0120","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta17120","article-title":"Positron emission tomography\/computerised tomography imaging in detecting and managing recurrent cervical cancer: systematic review of evidence, elicitation of subjective probabilities and economic modelling","volume":"17","author":"Meads","year":"2013","journal-title":"Health Technol. Assess."},{"key":"10.1016\/j.ygyno.2015.02.021_bb0125","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/S0090-8258(03)00256-7","article-title":"The role of PET scanning in the detection of recurrent cervical cancer","volume":"90","author":"Havrilesky","year":"2003","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2015.02.021_bb0130","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1001\/jamaophthalmol.2013.564","article-title":"Radiation-related cancer risk associate with surveillance imaging for metastasis from choroidal melanoma","volume":"131","author":"Wen","year":"2013","journal-title":"JAMA Opthalmol."},{"key":"10.1016\/j.ygyno.2015.02.021_bb0135","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1056\/NEJM198310133091503","article-title":"A radioimmunoassay using a monoclonal antibody to monitor the course of epithelial ovarian cancer","volume":"309","author":"Bast","year":"1983","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ygyno.2015.02.021_bb0140","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1001\/jama.2011.766","article-title":"Effect of screening on ovarian cancer mortality: the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Randomized Controlled Trial","volume":"305","author":"Buys","year":"2011","journal-title":"JAMA"},{"key":"10.1016\/j.ygyno.2015.02.021_bb0145","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/S1470-2045(09)70026-9","article-title":"Sensitivity and specificity of multimodal and ultrasound screening for ovarian cancer, and stage distribution of detected cancers: results of the prevalence screen of the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS)","volume":"10","author":"Menon","year":"2009","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.ygyno.2015.02.021_bb0150","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1097\/AOG.0b013e3181a106d4","article-title":"American College of O, Gynecologists, Bulletins\u2014Gynecology ACoP, Genetics ACo, Society of Gynecologic O. ACOG Practice Bulletin No. 103: hereditary breast and ovarian cancer syndrome","volume":"113","year":"2009","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.ygyno.2015.02.021_bb0155","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1200\/JCO.2011.39.7638","article-title":"Results of annual screening in phase I of the United Kingdom familial ovarian cancer screening study highlight the need for strict adherence to screening schedule","volume":"31","author":"Rosenthal","year":"2013","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ygyno.2015.02.021_bb0160","doi-asserted-by":"crossref","first-page":"206s","DOI":"10.1200\/JCO.2003.02.955","article-title":"Calculation of the risk of ovarian cancer from serial CA-125 values for preclinical detection in postmenopausal women","volume":"21","author":"Skates","year":"2003","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ygyno.2015.02.021_bb0165","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1158\/1940-6207.CAPR-10-0402","article-title":"Large prospective study of ovarian cancer screening in high-risk women: CA125 cut-point defined by menopausal status","volume":"4","author":"Skates","year":"2011","journal-title":"Cancer Prev. Res. (Phila.)"},{"key":"10.1016\/j.ygyno.2015.02.021_bb0170","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.6004\/jnccn.2013.0142","article-title":"Ovarian cancer, version 2. 2013","volume":"11","author":"Morgan","year":"2013","journal-title":"J. Natl. Compr. Cancer Netw."},{"key":"10.1016\/j.ygyno.2015.02.021_bb0175","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1097\/AOG.0b013e31821477db","article-title":"American College of O, Gynecologists Committee on Gynecologic P. Committee Opinion No. 477: the role of the obstetrician\u2013gynecologist in the early detection of epithelial ovarian cancer","volume":"117","year":"2011","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.ygyno.2015.02.021_bb0180","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1097\/AOG.0b013e318224fce2","article-title":"Evaluation of the diagnostic accuracy of the risk of ovarian malignancy algorithm in women with a pelvic mass","volume":"118","author":"Moore","year":"2011","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.ygyno.2015.02.021_bb0185","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1097\/AOG.0b013e31821b5118","article-title":"Effectiveness of a multivariate index assay in the preoperative assessment of ovarian tumors","volume":"117","author":"Ueland","year":"2011","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.ygyno.2015.02.021_bb0190","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.ygyno.2012.11.022","article-title":"Ovarian malignancy risk stratification of the adnexal mass using a multivariate index assay","volume":"128","author":"Bristow","year":"2013","journal-title":"Gynecol. Oncol."},{"issue":"351","key":"10.1016\/j.ygyno.2015.02.021_bb0195","first-page":"e1","article-title":"Serum HE4 levels are less frequently elevated than CA125 in women with benign gynecologic disorders","volume":"206","author":"Moore","year":"2012","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.ygyno.2015.02.021_bb0200","doi-asserted-by":"crossref","first-page":"S75","DOI":"10.1016\/j.ygyno.2011.12.179","article-title":"Comparative effectiveness of three triage strategies for women presenting to a gynecologist with a pelvic mass","volume":"125","author":"Havrilesky","year":"2012","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2015.02.021_bb0205","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1056\/NEJMoa1000678","article-title":"Early palliative care for patients with metastatic non-small-cell lung cancer","volume":"363","author":"Temel","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ygyno.2015.02.021_bb0210","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1136\/bmj.320.7233.469","article-title":"Extent and determinants of error in doctors' prognoses in terminally ill patients: prospective cohort study","volume":"320","author":"Christakis","year":"2000","journal-title":"BMJ"},{"key":"10.1016\/j.ygyno.2015.02.021_bb0215","series-title":"The Dartmouth Atlas Project: Dartmouth College","article-title":"Trends in cancer care near the end of life: a Dartmouth Atlas of Health Care Brief","author":"Goodman","year":"2013"},{"key":"10.1016\/j.ygyno.2015.02.021_bb0220","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.ygyno.2012.06.025","article-title":"The utilization of palliative care in gynecologic oncology patients near the end of life","volume":"127","author":"Fauci","year":"2012","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2015.02.021_bb0225","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.ygyno.2013.03.020","article-title":"Outpatient end of life discussions shorten hospital admissions in gynecologic oncology patients","volume":"130","author":"Doll","year":"2013","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2015.02.021_bb0230","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1089\/jpm.2012.0243","article-title":"Assessing the financial impact of an inpatient acute palliative care unit in a tertiary care teaching hospital","volume":"16","author":"Albanese","year":"2013","journal-title":"J. Palliat. Med."},{"key":"10.1016\/j.ygyno.2015.02.021_bb0235","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1089\/jpm.2007.0055","article-title":"Impact of an inpatient palliative care team: a randomized control trial","volume":"11","author":"Gade","year":"2008","journal-title":"J. Palliat. Med."},{"key":"10.1016\/j.ygyno.2015.02.021_bb0240","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1111\/j.1532-5415.2007.01234.x","article-title":"Increased satisfaction with care and lower costs: results of a randomized trial of in-home palliative care","volume":"55","author":"Brumley","year":"2007","journal-title":"J. Am. Geriatr. Soc."},{"key":"10.1016\/j.ygyno.2015.02.021_bb0245","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1056\/NEJMp1215620","article-title":"Generalist plus specialist palliative care\u2014creating a more sustainable model","volume":"368","author":"Quill","year":"2013","journal-title":"N. Engl. J. Med."}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825815006666?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825815006666?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,24]],"date-time":"2018-09-24T15:51:24Z","timestamp":1537804284000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825815006666"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5]]},"references-count":48,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,5]]}},"alternative-id":["S0090825815006666"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2015.02.021","relation":{},"ISSN":["0090-8258"],"issn-type":[{"type":"print","value":"0090-8258"}],"subject":[],"published":{"date-parts":[[2015,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Improving quality and decreasing cost in gynecologic oncology care. Society of gynecologic oncology recommendations for clinical practice","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2015.02.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}